Progyny, Inc.
Progyny, Inc. (Nasdaq: PGNY) provides employer-sponsored fertility, family-building and women’s health benefits. Its services include fertility treatment benefits using its Smart Cycle plan design, integrated fertility pharmacy benefits through Progyny Rx, pregnancy and postpartum support, menopause and midlife care,… From the company’s description.
Over the twelve months to Sep 30, 2026, Progyny, Inc. reported revenue of $1.34B, up 5.5% from a year earlier, and net income of $91.02M. Its operating margin was 9.4%, and operations generated $207.18M in cash. In fiscal 2025, it reported revenue of $1.29B, up 10.4% from fiscal 2024, and net income of $58.52M.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What Progyny, Inc. does
In the company’s own words
Progyny, Inc. (Nasdaq: PGNY) provides employer-sponsored fertility, family-building and women’s health benefits. Its services include fertility treatment benefits using its Smart Cycle plan design, integrated fertility pharmacy benefits through Progyny Rx, pregnancy and postpartum support, menopause and midlife care, benefit and leave navigation, and parent and child wellbeing programs. Employers contract for these benefits for employees and covered dependents; members receive clinical guidance, concierge support and access to a network of fertility and women’s health providers. The company also administers reimbursements for services such as adoption, surrogacy, doula care and travel for medical treatment, and offers benefits internationally. Progyny launched its fertility benefits solution in 2016 and has since expanded into additional areas of women’s health and family building. As of December 31, 2025, it had contracts with more than 590 employers covering approximately 7.2 million lives, and employed 856 people. Its registered brands include Progyny, Smart Cycle and UnPack It.
Company details
- Sector
- Health Care
- Industry (SIC)
- Health Services
- Headquarters
- NEW YORK, NY
- Fiscal year end
- December
- CIK
- 1551306
- SIC
- 8090
Financial performance, year by year
Fiscal 2019–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns Progyny, Inc. — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · Progyny, Inc.’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Could not be determined for this company: bond issues.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do Progyny, Inc. and its peers compare on margins and cash generation over ten years?”
- “Where did five years of Progyny, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in Progyny, Inc.'s last four quarterly filings that the numbers alone won't show?”